Paasa Logo
ResMed Inc. logo
RMDNYSEMarket closedOpens 9:30am ET

ResMed Inc.

$222.00Last updated
+$0.11 (0.05%)Past day
Timezone

ResMed Inc. (NYSE: RMD) is trading at $222.00, about ₹21,285 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.05% today. Indian residents can buy ResMed from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$220.75
Previous close:$221.89
Volume:722.14K

Today's low

$220.13

Today's high

$223.22

52 week low

$180.27

52 week high

$284.87

RMD opened at $220.75, closed previously at $221.89, and has traded between $180.27 and $284.87 over the past 52 weeks.

About

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Country
US
CEO
Michael J. Farrell
Exchange listed on
NYSE
Industry
Medical - Instruments & Supplies
Base currency
USD
Full Time Employees
11,370
Sector
Healthcare
IPO date
02/06/1995

Key statistics

Avg. volume

1.49M

Market cap

$32.20B

P/E Ratio

21.26

Price-to-sales ratio

5.70

Enterprise value

$31.56B

Free cash flow yield

8.97%

Debt-to-equity ratio

0.13

Return on equity

23.88%

ROIC

19.11%

Beta

0.77

Dividend yield

1.11%

Last dividend

$2.46

Financial overview

Revenue

$5.65B

Earnings per share

$10.44

Free cash flow

$1.65B

Net profit margin

26.94%

Gross margin

61.16%

EBITDA

$2.15B

Revenue growth

9.85%

Similar securities

This is not an investment recommendation

How to buy ResMed from India

Indian residents can buy ResMed shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for ResMed and place an order

    Find ResMed by name or by its ticker, RMD, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. ResMed trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your ResMed position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in ResMed from India

Trading and taxes when buying ResMed from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. ResMed’s current yield is 1.11%.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy ResMed stock?

Yes. ResMed (RMD) has been listed on the New York Stock Exchange since 1995, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one ResMed share cost in rupees?

One ResMed share is $222.00 — about ₹21,285 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the ResMed price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying ResMed from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy ResMed with less than the price of one share?

Yes. A whole ResMed share is $222.00, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.

How are gains on ResMed shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the ResMed price. Paasa issues a capital-gains statement for your return.

Does ResMed pay a dividend, and how is it taxed in India?

Yes. ResMed pays a dividend and the current yield is 1.11%; the last declared dividend was $2.46 per share, about ₹235.86. Dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade ResMed from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on ResMed shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare ResMed shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your ResMed holding, its cost and its closing value.

How do I sell ResMed and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.